文献速递病毒性肝炎

HBsAg水平可用于排除HBeAg阳性慢性乙型肝炎患者的肝硬化:SONIC-B研究结果

Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study.
PubMed 文献 · J Infect Dis · 2022-01-01

基于SONIC-B数据库(8项全球随机试验和2个大型肝病中心)的2779例患者数据,其中1866例HBeAg阳性、322例肝硬化。基因型特异性HBsAg界值阴性预测值>97%,误分类率≤7.1%,可作为FIB-4的辅助工具排除肝硬化。

要点

  • HBeAg阳性患者中HBsAg水平越低,显著纤维化和肝硬化风险越高
  • 基因型特异性HBsAg界值阴性预测值>97%,可用于排除肝硬化
  • HBsAg界值可作为FIB-4的辅助手段,减少进一步检查需求

核心结论

  • 基因型特异性HBsAg界值可用于排除基因B、C、D型HBeAg阳性患者的肝硬化,并可作为FIB-4的辅助工具减少进一步检查。

研究设计与样本

  • 分析SONIC-B数据库,该数据库包含8项全球随机试验和2个大型肝病中心的数据,共2779例患者。

主要发现

  • 在HBeAg阴性患者中未观察到HBsAg水平与纤维化或肝硬化的关系。
  • 在HBeAg阳性患者中,基因型特异性HBsAg界值的阴性预测值>97%,误分类率≤7.1%。
  • 在FIB-4无法排除肝硬化的患者中,HBsAg界值的诊断性能相当。

关键数值与推荐

  • 基因型特异性HBsAg界值的阴性预测值>97%,误分类率≤7.1%。

临床怎么用

  • 对于HBeAg阳性、基因B、C、D型的慢性乙型肝炎患者,可考虑使用基因型特异性HBsAg界值辅助排除肝硬化。
  • HBsAg界值可与FIB-4联合使用,以减少不必要的进一步检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum hepatitis B surface antigen (HBsAg) levels correlate with the duration of chronic hepatitis B virus (HBV) infection and may predict the extent of hepatic fibrosis. METHODS: We analyzed data from the SONIC-B database, which contains data from 8 global randomized trials and 2 large hepatology centers. Relationship between HBsAg levels and presence of significant fibrosis (Ishak 3-4) or cirrhosis (Ishak 5-6) were explored, and clinically relevant cutoffs were identified to rule out cirrhosis. RESULTS: The dataset included 2779 patients: 1866 hepatitis B e antigen (HBeAg)-positive; 322 with cirrhosis. Among HBeAg-positive patients, lower HBsAg levels were associated with higher rates of significant fibrosis (odds ratio [OR], 0.419; P < .001) and cirrhosis (OR, 0.435; P < .001). No relationship was observed among HBeAg-negative patients. Among HBeAg-positive patients, genotype-specific HBsAg cutoffs had excellent negative predictive values (>97%) and low misclassification rates (≤7.1%) and may therefore have utility in ruling out cirrhosis. Diagnostic performance of the HBsAg cutoffs was comparable among patients in whom cirrhosis could not be ruled out with fibrosis 4 (FIB-4). CONCLUSIONS: Hepatitis B virus genotype-specific HBsAg cutoffs may have utility in ruling out presence of cirrhosis in HBeAg-positive patients with genotypes B, C, and D and can be an adjunct to FIB-4 to reduce the need for further testing.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sonneveld MJ, Hansen BE, Brouwer WP, et al. Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study. J Infect Dis. 2022. PMID: 32318704. doi:10.1093/infdis/jiaa192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。